Dr. Mehta brings over two decades of experience in the pharma and biotech industry, during which he has successfully designed and implemented innovative solutions, established global commercial operations, and led cross-functional teams. During his career, he has garnered a deep understanding of

Richard Steinhart brings significant financial and strategic experience in the biotechnology and medical device industries. Prior to joining BioXcel Therapeutics, Richard served as Vice President and CFO at Remedy Pharmaceuticals, Inc., until it sold its only asset, CIRARA, to Biogen for $120M plus

Dr. Frank Yocca is an accomplished R&D executive and scientist with extensive experience leading global biopharmaceutical companies. He has wide-ranging expertise in leading high-performing, world-class teams in drug discovery and development whose efforts have resulted in a number of prominent

Dr. Vince O’Neill has significant expertise in therapeutic and diagnostic product development. He joined BioXcel Therapeutics in 2017 as Vice President and Chief Medical Officer, later Senior Vice President and Chief Medical Officer, and played an instrumental role in the Company’s SERENITY I and

Javier Rodriguez has over 20 years of extensive strategic and legal experience within the biopharmaceutical industry. Prior to joining BioXcel Therapeutics, he served as Chief Legal Officer at Indivior PLC, where he oversaw legal affairs, data privacy compliance and corporate governance matters for

Matt Wiley has over 25 years of sales, marketing, and strategy experience across multiple specialty product launches. Prior to joining BioXcel Therapeutics, he served as Chief Commercial Officer at VYNE Therapeutics, overseeing all commercial objectives related to the launch of the company’s first